Colorectal Cancer

A new analysis links higher triglyceride-glucose (TyG) and TyG–body mass index (TyG-BMI) levels to increased colorectal cancer (CRC) risk, especially among women, but not mortality.

Emerging research highlights how vitamin D boosts immunity and reduces colorectal cancer (CRC) risk by regulating inflammation and cell growth.

There has been a sharp increase in colorectal and pancreatic cancer rates among Americans under 55 years, despite declines in older adults, according to a new study.

Findings from a new study reveal how hurricanes and the pandemic disrupted colorectal cancer (CRC) screenings in Puerto Rico, leading to a rise in late-stage diagnoses.

The combination of nivolumab with ipilimumab was approved for unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) colorectal cancer.

Patient navigation and mailed outreach improved colorectal cancer screening rates in rural clinics, but follow-up colonoscopy participation remains low.

Clinical characteristics were associated with different survival outcomes in patients treated with immune checkpoint inhibitor–based therapy.

Michael Sapienza, CEO of the Colorectal Cancer Alliance, discusses ways that physicians can support patients through their colorectal cancer journey.

Biological age, rather than chronological age, may be a stronger predictor of colorectal cancer risk—especially in older adults.

The American College of Gastroenterology warns millions may lose access to life-saving colorectal cancer screenings.

Here are key facts, risk factors, and life-saving screening recommendations for colorectal cancer prevention and treatment.

The US Multi-Society Task Force updates 2014 recommendations, emphasizing split-dose prep, diet flexibility, and quality tracking.

When combined with chemotherapy, cetuximab shows promising efficacy for optimizing treatment strategies for patients with metastatic colorectal cancer.

People who regularly consumed yogurt had lower rates of colorectal cancer–positive Bifidobacterium.

Study results show most patients prefer more frequent colonoscopies, but specialist recommendations drive acceptance of extended intervals.

Kim Newcomer, director of volunteers, Colorectal Cancer Alliance, shares findings from a survey on colorectal cancer care inequities, and how to address these challenges.

Higher calcium intake was associated with reduced colorectal cancer risk across tumor sites and calcium sources, according to one study.

Researchers have developed an evaluation protocol index to optimize postoperative recovery.

Kim Newcomer, director of volunteers, Colorectal Cancer Alliance, discusses a study conducted with Takeda and the Harris Poll, focusing on the treatment experiences of patients with metastatic colorectal cancer.

The companies announced the deal in a statement February 5, 2025, noting that the first patient had enrolled in a prospective clinical study using the test to monitor cancer recurrence across multiple solid tumor types.

World Cancer Day also marks the start of the ‘United by Unique’ campaign, which seeks to highlight how each person’s journey with cancer is unique, even though the patients, caregivers, and health care teams who are touched by cancer are united by shared goals.

New data showed that prior malignancy may influence survival outcomes in patients with metastatic colorectal cancer, highlighting the need for standardized treatment approaches.

With high-sensitivity and strong negative predictive value, this artificial intelligence (AI)-powered tool enhances early colorectal cancer (CRC) detection and risk stratification in primary care.

Waist circumference and waist-to-hip ratio show stronger links to colorectal cancer (CRC) than body mass index (BMI), a new study has found.

The combination treatment specifically targets KRAS-mutated metastatic colorectal cancer (CRC) to improve progression-free survival.